Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07318480Recruiting
Brain stimulation for drug addiction
This study tests a type of brain stimulation (called tDCS) to help people reduce their use of stimulants (like crack/cocaine) or opioids. It might help lessen cravings and improve treatment outcomes.
New York, New YorkAges 18–60 - NCT07321652RecruitingPhase 3
Sonrotoclax plus zanubrutinib for untreated CLL or SLL
This trial tests whether adding a new drug, sonrotoclax, to the standard treatment zanubrutinib works better for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who haven't had treatment before. It's for patients aged 65 and older who need therapy due to symptoms or blood cell issues.
Birmingham, AlabamaAges 65 years+ - NCT07319416Recruiting
Ultrasound study for PRRT response in GEP-NET
This trial tests if a special ultrasound can help doctors see how well treatment is working for a type of slow-growing gut or pancreas cancer (GEP-NET). It may help guide your care if you are starting a therapy called PRRT (peptide receptor radionuclide therapy).
Rome, RomeAges 18 years+ - NCT04716140Recruiting
Study of outcomes after bunion surgery for cartilage damage
This study looks at how well bunion (hallux valgus) surgery works, especially when there is cartilage damage in the joint. The goal is to see what factors predict better or worse outcomes after treatment.
GhentAges 30–60 - NCT04847635Recruiting
Laser test for aging-related macular spots under the retina
This trial studies a mild (“subthreshold”) laser treatment for reticular pseudodrusen (RPD) caused by age-related macular degeneration (AMD). If you qualify, the goal is to see whether the laser helps preserve or improve vision by targeting these specific eye changes.
GenovaAges 55 years+ - NCT05595447RecruitingPhase 2/Phase 3
Testing new treatment for Hodgkin lymphoma that came back
This study tests a treatment plan for adults with Hodgkin lymphoma that has returned or did not respond to ABVD chemotherapy. It may help people with a higher-risk pattern of disease, as long as their organ function and overall health meet study limits.
León, GuanajuatoAges 15–90 - NCT05741073Recruiting
Study of European registry data for advanced skin cancers
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
BrusselsAges 18 years+ - NCT06581081Recruiting
CAR-T therapy with or without stem cell transplant for B-cell leukemia
This trial tests a CD19-targeted CAR-T cell therapy (S1904) for people with B-cell acute lymphoblastic leukemia that has come back or not responded to treatment. After CAR-T, some patients may go on to a stem cell transplant. The goal is to see if the CAR-T can lead to remission and who needs a transplant.
Beijing, Beijing MunicipalityAges 12–65 - NCT06528613Recruiting
BPH symptom study with combo treatment
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
Athens, GreeceAges 18–100 - NCT06514677Recruiting
Nonsurgical treatment for implant infection with ultrasonic carbon tip
This study tests whether using a special ultrasonic carbon tip (a gentle cleaning tool) can treat infection around a dental implant without surgery. It is for people with a single problem implant who are otherwise healthy and have good oral hygiene.
KütahyaAges 18–99 - NCT06823570Recruiting
Exercise and blood pressure medicine for better blood vessels
This study is testing whether a combination of blood pressure medication and a supervised exercise program can improve the health of your blood vessels. It's for people with mild to moderate high blood pressure who are not already on medication.
Düsseldorf, DüsseldorfAges 18 years+ - NCT06864221Recruiting
How fat molecules in blood affect liver cancer radiotherapy
This study looks at whether certain fats in your blood can help predict how well radiotherapy works for liver cancer. If you are getting radiation for liver cancer, your blood samples may help doctors learn more about your treatment response.
Guangzhou, GuangdongAges 18–80 - NCT06858384Recruiting
Optimizing PPI use through education and intervention
This trial tests whether educating doctors can reduce unnecessary prescriptions of proton pump inhibitors (PPIs, a type of acid-reducing medicine). If you are an adult patient who has been prescribed a PPI that might not be needed, your doctor may join this study to improve your care.
Ras al-KhaimahAges 18 years+ - NCT06873269Recruiting
Holmium-166 radiation therapy for liver cancer
This trial tests a radiation treatment for liver cancer that cannot be removed with surgery or ablation. Tiny beads containing Holmium-166 are injected into the liver's blood supply to target the tumor directly.
BrusselsAges 18 years+ - NCT06871605Recruiting
Nerve blocks for chronic groin pain after hernia surgery
This study compares two types of nerve blocks (injections near the nerves) to treat chronic groin pain after hernia surgery. The goal is to find which block provides better pain relief.
AnkaraAges 18 years+ - NCT04996017RecruitingPhase 3
Atezolizumab after surgery for malignant pleural mesothelioma
This study tests whether atezolizumab given after surgery and chemotherapy can lower the risk of mesothelioma coming back compared with a placebo. It may help by boosting the immune system to control remaining microscopic cancer cells.
Meldola, ITAòYAges 18 years+ - NCT04873050RecruitingPhase 4
Medication and lifestyle plan to bring blood sugar to normal
This Phase 4 study looks at how to help women with a recent history of gestational diabetes get their blood sugar back toward normal levels. It likely includes blood-sugar testing and a controlled diet period to see what works best.
Baton Rouge, LouisianaAges 18–45 - NCT06179498Recruiting
Partner navigation for hepatitis C treatment in young people who inject drugs
This trial offers a partner navigation program to help young people who inject drugs and their main injecting partner work together to get treatment for hepatitis C (a liver infection).
San Francisco, CaliforniaAges 18 years+ - NCT05825170Recruiting
Hyaluronic acid lip filler for lip deformity after cleft surgery
This trial tests a hyaluronic acid filler (placed in the lips) to improve lip shape in people who had cleft lip and palate surgery. It looks at how well the filler works and how safe it is for your lips and surrounding skin.
Lille, NordAges 18 years+ - NCT06030947Recruiting
Micro graft for treating multiple gum recessions
This trial tests a new micro connective tissue graft to cover multiple areas where your gums have pulled away from your teeth (recession). It may help if you have healthy gums but several receding spots on your upper or lower jaw.
DubaiAges 18–60 - NCT06033378Recruiting
Blood pressure treatment for ICU patients with brain bleed
This trial tests a blood pressure management strategy for patients in the ICU after a bleeding stroke caused by a brain aneurysm. It aims to see if carefully controlling blood pressure can help prevent a dangerous tightening of blood vessels in the brain.
UmeåAges 18 years+ - NCT07308886RecruitingPhase 2
CYT107 for Kaposi sarcoma in HIV patients with low CD4
This trial tests an experimental drug (CYT107) that boosts the immune system to help fight Kaposi sarcoma in people with HIV who have a low CD4 count despite good HIV treatment. It aims to see if the drug can improve KS tumors and quality of life.
Bethesda, MarylandAges 18–120 - NCT07313059Recruiting
Clonal hematopoiesis study for people 55+
This study looks at a condition called clonal hematopoiesis (CH), where some blood cells have changes that may affect their health. It aims to prevent, treat, and better understand CH. You may qualify if you are 55 or older and have low blood counts that persist over time.
Canberra, Australian Capital TerritoryAges 55 years+ - NCT07307469Enrolling by invitation
Extended access to ZVS101e for BCD patients
This trial offers compassionate use of the gene therapy ZVS101e for people with Bietti crystalline dystrophy (BCD) who were in the control group of an earlier study. It aims to give extended treatment access to those who didn't receive the experimental therapy before.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.